Table 2 Cost-effectiveness results of base case analysis
From: Long-term cost-effectiveness of health behaviour intervention to manage type 2 diabetes in Nepal
Time horizons and perspective | Intervention | Control | Incremental | ICER# (95%CI) | PBC## (%) | |||
|---|---|---|---|---|---|---|---|---|
Costs in mean* (SD) | QALYs in mean ** (SD) | Costs in mean* (SD) | QALYs in mean** (SD) | Costs (95%CI) | QALYs (95% CI) | |||
5-Year horizon | ||||||||
Healthcare system | 537 (0.20) | 4.64 (0.01) | 258 (0.28) | 4.20 (0.002) | 280 (230 to 329) | 0.44 (0.36 to 0.52) | 636 (524 to 748) | 57.29 |
Societal | 670 (0.20) | 4.64 (0.01) | 354 (0.28) | 4.20 (0.001) | 317 (260 to 372) | 0.44 (0.36 to 0.53) | 719 (592 to 846) | 57.47 |
10-Year horizon | ||||||||
Healthcare system | 1069 (0.82) | 9.12 (0.02) | 506 (1.19) | 8.29 (0.02) | 563 (464 to 662) | 0.83 (0.68 to 0.99) | 678 (558 to 798) | 76.93 |
Societal | 1334 (0.82) | 9.12 (0.02) | 698 (1.19) | 8.29 (0.02) | 636 (524 to 748) | 0.83 (0.68 to 0.99) | 766 (631 to 902) | 76.31 |
20-Year horizon | ||||||||
Healthcare system | 2067 (4.44) | 17.03 (0.07) | 939 (4) | 15.26 (0.08) | 1128 (929 to 1326) | 1.77 (1.46 to 2.12) | 637 (525 to 749) | 96.26 |
Societal | 2442 (4) | 17.03 (0.07) | 1275 (4) | 15.26 (0.08) | 1167 (1049 to 1498) | 1.77 (1.46 to 2.12) | 659 (592 to 846) | 96.14 |
30-Year horizon | ||||||||
Healthcare system | 2912 (10) | 22.97 (0.14) | 1263 (8) | 20.36 (0.14) | 1649 (1358 to 1940) | 2.61 (2.15 to 3.12) | 632 (520 to 743) | 97.97 |
Societal | 3709 (10) | 22.97 (0.14) | 1840 (8) | 20.36 (0.14) | 1869 (1539 to 2198) | 2.61 (2.15 to 3.12) | 716 (589 to 842) | 97.95 |
Lifetime time horizon | ||||||||
Healthcare system | 6035 (39) | 31.73 (0.33) | 1742 (27) | 27.85 (0.29) | 4293 (3535 to 5050) | 3.88 (3.20 to 4.64) | 1106 (911 to 1302) | 99.98 |
Societal | 6965 (39) | 31.73 (0.33) | 2415 (27) | 27.85 (0.29) | 4550 (3747 to 5352) | 3.88 (3.20 to 4.64) | 1173 (986 to 1379) | 99.98 |